VISHAY INTERTECHNOLOGY INC
For the period ended Mar 29, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2025 · Filed May 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Consolidated Condensed Financial Statements
Note 1 – Basis of Presentation
The accompanying unaudited consolidated condensed financial statements of Vishay Intertechnology, Inc. (“Vishay” or the “Company”) have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all information and footnotes necessary for presentation of financial position, results of operations, and cash flows required by accounting principles generally accepted in the United States (“GAAP”) for complete financial statements. The information furnished reflects all normal recurring adjustments which are, in the opinion of management, necessary for a fair summary of the financial position, results of operations, and cash flows for the interim periods presented. The financial statements should be read in conjunction with the consolidated financial statements filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The results of operations for the three fiscal months ended March 29, 2025 are not necessarily indicative of the results to be expected for the full year.
The Company reports interim financial information for 13-week periods beginning on a Sunday and ending on a Saturday, except for the first fiscal quarter, which always begins on January 1, and the fourth fiscal quarter, which always ends on December 31. The four fiscal quarters in 2025 end on March 29, 2025, June 28, 2025, September 27, 2025, and December 31, 2025, respectively. The four fiscal quarters in 2024 ended on March 30, 2024, June 29, 2024, September 28, 2024, and December 31, 2024, respectively.
Reclassifications
Certain prior period amounts have been reclassified to conform to the current financial statement presentation.
Note 2 – Restructuring and Related Activities
In September 2024, the Company announced the implementation of restructuring actions designed to optimize the Company’s manufacturing footprint and streamline business decision making.
The following table summarizes activity to date related to this program:
| Expense recorded in 2024 | $40,614 |
|---|---|
| Utilized | (8,734) |
| Foreign currency translation | (1,292) |
| Balance at December 31, 2024 | $30,588 |
| Utilized | (1,596) |
| Foreign currency translation | 476 |
| Balance at March 29, 2025 | $29,468 |
Severance payment terms vary by country, but are generally paid in a lump sum at cessation of employment. Some payments are made over an extended period. The current portion of the liability is $14,806 and is included in other accrued expenses in the accompanying consolidated condensed balance sheet. The non-current portion of the liability is $14,662 and is included in other liabilities in the accompanying consolidated condensed balance sheet.
Note 3 – Leases
The net right of use assets and lease liabilities recognized on the consolidated condensed balance sheets for the Company's operating leases were as follows:
| March 29, 2025 | December 31, 2024 | |
|---|---|---|
| Right of use assets | ||
| Operating Leases | ||
| Buildings and improvements | $112,273 | $112,528 |
| Machinery and equipment | 5,172 | 5,425 |
| Total | $117,445 | $117,953 |
| Current lease liabilities | ||
| Operating Leases | ||
| Buildings and improvements | $23,327 | $22,993 |
| Machinery and equipment | 2,852 | 2,908 |
| Total | $26,179 | $25,901 |
| Long-term lease liabilities | ||
| Operating Leases | ||
| Buildings and improvements | $90,928 | $91,772 |
| Machinery and equipment | 2,222 | 2,446 |
| Total | $93,150 | $94,218 |
| Total lease liabilities | $119,329 | $120,119 |
Lease expense is classified in the statements of operations based on asset use. Total lease cost recognized on the consolidated condensed statements of operations is as follows:
| Fiscal quarters ended | ||||
|---|---|---|---|---|
| March 29, 2025 · March 30, 2024 | ||||
| Lease expense | ||||
| Operating lease expense | $ | 6,956 | $ | 7,293 |
| Short-term lease expense | 407 | 256 | ||
| Variable lease expense | 160 | 214 | ||
| Total lease expense | $ | 7,523 | $ | 7,763 |
The Company paid $7,242 and $7,540 for its operating leases in the three fiscal months ended March 29, 2025 and March 30, 2024, respectively, which are included in operating cash flows on the consolidated condensed statements of cash flows. The weighted-average remaining lease term for the Company's operating leases is 8.6 years and the weighted-average discount rate is 6.6% as of March 29, 2025.
The undiscounted future lease payments for the Company's operating lease liabilities are as follows:
| 2025 (excluding the three fiscal months ended March 29, 2025) | $20,416 |
| 2026 | 23,901 |
| 2027 | 20,762 |
| 2028 | 16,214 |
| 2029 | 14,124 |
| Thereafter | 62,536 |
The undiscounted future lease payments presented in the table above include payments through the term of the lease, which may include periods beyond the noncancellable term. The difference between the total payments above and the lease liability balance is due to the discount rate used to calculate lease liabilities.
Note 4 – Income Taxes
The provision for income taxes consists of provisions for federal, state, and foreign income taxes. The effective tax rates for the periods ended March 29, 2025 and March 30, 2024 reflect the Company’s expected tax rate on reported income before income tax and tax adjustments. The Company operates in a global environment with significant operations in various jurisdictions outside the United States. Accordingly, the consolidated income tax rate is a composite rate reflecting the Company’s earnings and the applicable tax rates in the various jurisdictions where the Company operates.
In December 2021, the Organization for Economic Co-operation and Development (“OECD”) issued model rules for a new global minimum tax (“Pillar Two”). Various jurisdictions around the world have passed legislation to enact Pillar Two and certain Pillar Two rules are in effect for 2025. The United States has not adopted Pillar Two. The Company does not anticipate a material increase in income tax expense for 2025 due to Pillar Two and the Company is continuing to monitor Pillar Two developments and the potential future impact on its operations and income tax expense.
During the three fiscal months ended March 29, 2025, the liabilities for unrecognized tax benefits decreased $963 on a net basis, primarily due to the settlement of tax audits, partially offset by accruals for the current period.
Note 5 – Long-Term Debt
Long-term debt consists of the following:
| March 29, 2025 | December 31, 2024 | |
|---|---|---|
| Credit facility | $218,000 | $136,000 |
| Convertible senior notes, due 2025 | 41,911 | 41,911 |
| Convertible senior notes, due 2030 | 750,000 | 750,000 |
| Deferred financing costs | (21,676) | (22,892) |
| 988,235 | 905,019 | |
| Less current portion | - | - |
| $988,235 | $905,019 |
The following table summarizes some key facts and terms regarding the outstanding convertible senior notes as of March 29, 2025:
| 2025 Notes · 2030 Notes | |||
|---|---|---|---|
| Issuance date · June 12, 2018 · September 12, 2023 | |||
| Maturity date | June 15, 2025 | * | September 15, 2030 |
| Principal amount as of March 29, 2025 | $41,911 | $750,000 | |
| Cash coupon rate (per annum) | 2.25% | 2.25% | |
| Conversion rate (per $1 principal amount) | 32.2497 | 33.1609 | |
| Effective conversion price (per share) | $31.01 | $30.16 | |
| 130% of the current effective conversion price (per share) | n/a | ** | $39.21 |
*As the Company has the intent and ability to refinance its convertible senior notes due 2025 (the "2025 Notes") upon maturity using its revolving credit facility, the 2025 Notes remain classified as long-term liabilities.
**The 2025 Notes became convertible on December 15, 2024 and will remain convertible until maturity. Accordingly, 130% of the conversion price of the 2025 Notes is not applicable.
Deferred financing costs are recognized as non-cash interest expense. Non-cash interest expense was $1,223 and $1,213 for the fiscal quarters ended March 29, 2025 and March 30, 2024, respectively.
Note 6 – Stockholders' Equity
In 2022, the Company's Board of Directors adopted a Stockholder Return Policy that will remain in effect until such time as the Board votes to amend or rescind the policy. The Stockholder Return Policy calls for the Company to return a prescribed amount of cash flows on an annual basis. The Company intends to return such amounts directly, in the form of dividends, or indirectly, in the form of stock repurchases.
The following table summarizes activity pursuant to this policy:
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Dividends paid to stockholders | $13,562 | $13,752 |
| Stock repurchases | 12,538 | 12,538 |
| Total | $26,100 | $26,290 |
The repurchased shares are being held as treasury stock. The number of shares of common stock being held as treasury stock was 10,662,155 and 9,933,595 as of March 29, 2025 and December 31, 2024, respectively.
Note 7 – Revenue Recognition
Sales returns and allowances accrual activity is shown below:
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Beginning balance | $43,445 | $47,760 |
| Sales allowances | 20,186 | 25,276 |
| Credits issued | (25,589) | (24,084) |
| Foreign currency | 396 | (204) |
| Ending balance | $38,438 | $48,748 |
See disaggregated revenue information in Note 11.
Note 8 – Accumulated Other Comprehensive Income (Loss)
The cumulative balance of each component of other comprehensive income (loss) and the income tax effects allocated to each component are as follows:
| Pension and other post- retirement actuarial items · Currency translation adjustment · Total | ||||
|---|---|---|---|---|
| Balance at January 1, 2025 | $(10,956) | $(24,336) | $(35,292) | |
| Other comprehensive income (loss) before reclassifications | - | 30,902 | $30,902 | |
| Tax effect | - | - | $ | - |
| Other comprehensive income before reclassifications, net of tax | - | 30,902 | $30,902 | |
| Amounts reclassified out of AOCI | 262 | - | $262 | |
| Tax effect | 40 | - | $40 | |
| Amounts reclassified out of AOCI, net of tax | 302 | - | $302 | |
| Net other comprehensive income (loss) | $302 | $30,902 | $31,204 | |
| Balance at March 29, 2025 | $(10,654) | $6,566 | $(4,088) | |
Reclassifications of pension and other post-retirement actuarial items out of AOCI are included in the computation of net periodic benefit cost. See Note 9 for further information.
Note 9 – Pensions and Other Postretirement Benefits
The Company maintains various retirement benefit plans. The service cost component of net periodic pension cost is classified in costs of products sold or selling, general, and administrative expenses on the consolidated condensed statements of operations based on the respective employee's function. The other components of net periodic pension cost are classified as other expense on the consolidated condensed statements of operations.
Defined Benefit Pension Plans
The following table shows the components of the net periodic pension cost for the first fiscal quarters of 2025 and 2024 for the Company’s defined benefit pension plans:
| Fiscal quarter ended March 29, 2025 · Fiscal quarter ended March 30, 2024 | ||||||
|---|---|---|---|---|---|---|
| U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans | ||||||
| Net service cost | $ | - | $729 | $ | - | $790 |
| Interest cost | 380 | 1,488 | 381 | 1,686 | ||
| Expected return on plan assets | - | (540) | - | (596) | ||
| Amortization of prior service cost | 1 | 34 | 16 | 57 | ||
| Amortization of losses (gains) | - | 242 | (108) | 457 | ||
| Curtailment and settlement losses | - | 23 | - | 105 | ||
| Net periodic benefit cost | $381 | $1,976 | $289 | $2,499 | ||
Other Postretirement Benefits
The following table shows the components of the net periodic benefit cost for the first fiscal quarters of 2025 and 2024 for the Company’s other postretirement benefit plans:
| Fiscal quarter ended March 29, 2025 | Fiscal quarter ended March 30, 2024 | |||
|---|---|---|---|---|
| U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |
| Service cost | $5 | $55 | $5 | $60 |
| Interest cost | 51 | 56 | 53 | 61 |
| Amortization of losses (gains) | (52) | 14 | (60) | 21 |
| Net periodic benefit cost | $4 | $125 | $(2) | $142 |
Note 10 – Stock-Based Compensation
The following table summarizes stock-based compensation expense recognized:
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Restricted stock units ("RSUs") | $5,968 | $5,226 |
| Phantom stock units | 83 | 118 |
| Total | $6,051 | $5,344 |
The following table summarizes unrecognized compensation cost and the weighted average remaining amortization periods at March 29, 2025(amortization periods in years):
| Unrecognized Compensation Cost | Weighted Average Remaining Amortization Periods | |
|---|---|---|
| Restricted stock units | $34,156 | 2.3 |
| Phantom stock units | - | n/a |
| Total | $34,156 |
Restricted Stock Units
RSU activity as of March 29, 2025 and changes during the three fiscal months then ended are presented below(number of RSUs in thousands):
| Number of RSUs | Weighted Average Grant-date Fair Value per Unit | |
|---|---|---|
| Outstanding: | ||
| January 1, 2025 | 2,628 | $21.37 |
| Granted | 873 | 19.33 |
| Vested* | (728) | 21.76 |
| Cancelled or forfeited | (116) | 20.97 |
| Outstanding at March 29, 2025 | 2,657 | $20.61 |
| Expected to vest at March 29, 2025 | 1,985 | |
- The number of RSUs vested includes shares that the Company withheld on behalf of employees to satisfy the statutory tax withholding requirements.
The number of performance-based RSUs that are scheduled to vest increases ratably based on the achievement of defined performance and market criteria between the established target and maximum levels. RSUs with performance-based and market-based vesting criteria are expected to vest as follows(number of RSUs in thousands):
| Vesting Date | Expected to Vest | Not Expected to Vest | Total |
|---|---|---|---|
| January 1, 2026 | - | 137 | 137 |
| January 1, 2027 | - | 549 | 549 |
| January 1, 2028 | 433 | - | 433 |
| March 1, 2029 | 175 | - | 175 |
Phantom Stock Units
The following table summarizes the Company's phantom stock units activity(number of phantom stock units in thousands):
| Number of units | Grant-date Fair Value per Unit | |
|---|---|---|
| Outstanding: | ||
| January 1, 2025 | 128 | |
| Granted | 5 | $16.69 |
| Dividend equivalents issued | 1 | |
| Outstanding at March 29, 2025 | 134 | |
Note 11 – Segment Information
The following tables set forth business segment information:
| MOSFETs · Diodes · Optoelectronic Components · Resistors · Inductors · Capacitors · Corporate/ Other · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fiscal quarter ended March 29, 2025: | |||||||||
| Net revenues | $142,113 | $140,963 | $51,168 | $179,500 | $84,121 | $117,371 | $ | - | $715,236 |
| Cost of products sold (excluding depreciation) | $117,507 | $101,829 | $36,658 | $128,472 | $62,282 | $85,954 | $ | - | $532,702 |
| Depreciation expense in costs of products sold | 13,000 | 11,112 | 3,810 | 10,674 | 4,242 | 4,142 | - | 46,980 | |
| Total costs of products sold | $130,507 | $112,941 | $40,468 | $139,146 | $66,524 | $90,096 | $ | - | $579,682 |
| Gross profit | $11,606 | $28,022 | $10,700 | $40,354 | $17,597 | $27,275 | $ | - | $135,554 |
| Segment operating expenses | $20,345 | $6,825 | $5,281 | $9,203 | $3,695 | $6,701 | $ | - | $52,050 |
| Segment operating income (loss) | $(8,739) | $21,197 | $5,419 | $31,151 | $13,902 | $20,574 | $ | - | $83,504 |
| Total depreciation expense | $13,572 | $11,483 | $3,917 | $10,864 | $4,283 | $4,184 | $2,215 | $50,518 | |
| Capital expenditures | 46,303 | 4,329 | 712 | 3,047 | 584 | 5,975 | 619 | 61,569 | |
| Total assets as of March 29, 2025: | $1,080,665 | $735,150 | $354,747 | $976,991 | $334,823 | $467,561 | $250,305 | $4,200,242 | |
| Fiscal quarter ended March 30, 2024: | |||||||||
| Net revenues | $153,173 | $149,130 | $49,199 | $188,196 | $88,651 | $117,930 | $ | - | $746,279 |
| Cost of products sold (excluding depreciation) | $116,748 | $105,645 | $38,403 | $131,633 | $57,848 | $81,997 | $ | - | $532,274 |
| Depreciation expense in cost of products sold | 10,952 | 11,115 | 3,795 | 10,092 | 4,016 | 3,628 | - | 43,598 | |
| Total cost of products sold | $127,700 | $116,760 | $42,198 | $141,725 | $61,864 | $85,625 | $ | - | $575,872 |
| Gross profit | $25,473 | $32,370 | $7,001 | $46,471 | $26,787 | $32,305 | $ | - | $170,407 |
| Segment operating expenses | $17,426 | $6,359 | $5,508 | $8,298 | $3,606 | $5,776 | $ | - | $46,973 |
| Segment operating income | $8,047 | $26,011 | $1,493 | $38,173 | $23,181 | $26,529 | $ | - | $123,434 |
| Total depreciation expense | $11,329 | $11,486 | $3,888 | $10,270 | $4,044 | $3,682 | $2,224 | $46,923 | |
| Capital expenditures | 28,562 | 8,055 | 1,291 | 11,302 | 1,133 | 2,067 | 674 | 53,084 | |
| Total assets as of March 30, 2024: | $1,053,432 | $768,304 | $360,604 | $1,038,302 | $352,751 | $461,157 | $229,514 | $4,264,064 | |
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Reconciliation: | ||
| Segment Operating Income | $83,504 | $123,434 |
| Unallocated Selling, General, and Administrative Expenses | (82,689) | (80,763) |
| Consolidated Operating Income | $815 | $42,671 |
| Unallocated Other Income (Expense) | (5,043) | 1,591 |
| Consolidated Income Before Taxes | $(4,228) | $44,262 |
The Company has a broad line of products that it sells to OEMs, EMS companies, and independent distributors. The distribution of sales by customer type is shown below:
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Distributors | $388,493 | $382,480 |
| OEMs | 278,346 | 313,827 |
| EMS companies | 48,397 | 49,972 |
| Total Revenue | $715,236 | $746,279 |
Net revenues were attributable to customers in the following regions:
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Asia | $284,579 | $284,007 |
| Europe | 255,331 | 271,734 |
| Americas | 175,326 | 190,538 |
| Total Revenue | $715,236 | $746,279 |
The Company generates substantially all of its revenue from product sales to end customers in the industrial, automotive, computing, military and aerospace, consumer products, power supplies, medical, and telecommunications end markets. Sales by end market are presented below:
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Industrial | $244,926 | $248,128 |
| Automotive | 257,112 | 287,302 |
| Military and Aerospace | 76,317 | 83,356 |
| Medical | 36,532 | 34,389 |
| Other* | 100,349 | 93,104 |
| Total Revenue | $715,236 | $746,279 |
*Power supplies, telecommunications, consumer products, and computing.
Note 12 – Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share attributable to Vishay stockholders(shares in thousands):
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Numerator: | ||
| Net earnings (loss) attributable to Vishay stockholders | $(4,092) | $30,924 |
| Denominator: | ||
| Denominator for basic earnings (loss) per share: | ||
| Weighted average shares | 135,666 | 137,601 |
| Outstanding phantom stock units | 133 | 125 |
| Adjusted weighted average shares - basic | 135,799 | 137,726 |
| Effect of dilutive securities: | ||
| Restricted stock units | - | 750 |
| Dilutive potential common shares | - | 750 |
| Denominator for diluted earnings (loss) per share: | ||
| Adjusted weighted average shares - diluted | 135,799 | 138,476 |
| Basic earnings (loss) per share attributable to Vishay stockholders | $(0.03) | $0.22 |
| Diluted earnings (loss) per share attributable to Vishay stockholders | $(0.03) | $0.22 |
Diluted earnings (loss) per share for the periods presented do not reflect the following weighted average potential common shares that would have an antidilutive effect or have unsatisfied performance conditions(in thousands):
| Fiscal quarters ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Restricted stock units | 2,657 | 127 |
If the average market price of Vishay common stock is less than the effective conversion prices of the convertible senior notes due 2025 and due 2030, respectively, no shares are included in the diluted earnings (loss) per share computation for the convertible senior notes due 2025 and due 2030. Upon Vishay exercising its existing right to legally amend the indenture governing the convertible senior notes due 2025, Vishay will satisfy its conversion obligations by paying $1 cash per $1 principal amount of converted notes and settle any additional amounts due in common stock. Pursuant to the indenture governing the convertible senior notes due 2030, Vishay will satisfy its conversion obligations by paying $1 cash per $1 principal amount of converted notes and settle any additional amounts due in cash and/or common stock.
In connection with the issuance of the convertible senior notes due 2030, the Company entered into capped call transactions, which were not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive. The capped calls are intended to reduce the potential dilution to the Company's common stock in the event that at the time of conversion of the convertible senior notes due 2030 the Company's common stock price exceeds the conversion price of the convertible senior notes due 2030.
Note 13 – Fair Value Measurements
The following table provides the financial assets and liabilities carried at fair value measured on a recurring basis:
| Total Fair Value · Level 1 · Level 2 · Level 3 | |||||||
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Assets held in rabbi trusts | $51,381 | $23,033 | $28,348 | $ | - | ||
| Available for sale securities | $3,897 | 3,897 | - | - | |||
| $55,278 | $26,930 | $28,348 | $ | - | |||
| Liability: | |||||||
| Acquisitions contingent consideration | $3,696 | $ | - | $ | - | $3,696 | |
| Assets: | |||||||
| Assets held in rabbi trusts | $53,508 | $24,518 | $28,990 | $ | - | ||
| Available for sale securities | $4,043 | 4,043 | - | - | |||
| $57,551 | $28,561 | $28,990 | $ | - | |||
| Liability: | |||||||
| Acquisitions contingent consideration | $3,801 | $ | - | $ | - | $3,801 | |
There have been no changes in the classification of any financial instruments within the fair value hierarchy in the periods presented.
The Company maintains non-qualified trusts, referred to as “rabbi” trusts, to fund payments under deferred compensation and non-qualified pension plans. Rabbi trust assets consist primarily of marketable securities, classified as available-for-sale and company-owned life insurance assets. The marketable securities held in the rabbi trusts are valued using quoted market prices on the last business day of the period. The company-owned life insurance assets are valued in consultation with the Company’s insurance brokers using the value of underlying assets of the insurance contracts. The fair value measurement of the marketable securities held in the rabbi trust is considered a Level 1 measurement and the measurement of the company-owned life insurance assets is considered a Level 2 measurement within the fair value hierarchy.
The Company holds investments in debt securities that are intended to fund a portion of its pension and other postretirement benefit obligations outside of the United States. The investments are valued based on quoted market prices on the last business day of the period. The fair value measurement of the investments is considered a Level 1 measurement within the fair value hierarchy.
The Company may be required to make certain contingent consideration payments related to acquisitions. The fair value of these contingent payments is determined by estimating the net present value of the expected cash flows based on the probability of expected payments. The fair value measurement of the contingent consideration payments is considered a Level 3 measurement within the fair value hierarchy.
The fair value of the long-term debt, excluding the derivative liabilities and deferred financing costs, at March 29, 2025 and December 31, 2024 is approximately $939,000 and $850,600, respectively, compared to its carrying value, excluding the deferred financing costs, of $1,009,911 and $927,911, respectively. The Company estimates the fair value of its long-term debt using a combination of quoted market prices for similar financing arrangements and expected future payments discounted at risk-adjusted rates, which are considered Level 2 inputs.
At March 29, 2025 and December 31, 2024, the Company’s short-term investments were comprised of time deposits with financial institutions that have maturities that exceed 90 days from the date of acquisition; however they all mature within one year from the respective balance sheet dates. The Company's short-term investments are accounted for as held-to-maturity debt instruments, at amortized cost, which approximates their fair value. The investments are funded with excess cash not expected to be needed for operations prior to maturity; therefore, the Company believes it has the intent and ability to hold the short-term investments until maturity. At each reporting date, the Company performs an evaluation to determine if any unrealized losses are other-than-temporary. No other-than-temporary impairments have been recognized on these securities, and there areno unrecognized holding gains or losses for these securities during the periods presented. There have beenno transfers to or from the held-to-maturity classification. All decreases in the account balance are due to returns of principal at the securities’ maturity dates. Interest on the securities is recognized as interest income when earned.
At March 29, 2025 and December 31, 2024, the Company’s cash and cash equivalents were comprised of demand deposits, time deposits with maturities of three months or less when purchased, and money market funds. The Company estimates the fair value of its cash, cash equivalents, and short-term investments using Level 2 inputs. Based on the current interest rates for similar investments with comparable credit risk and time to maturity, the fair value of the Company's cash, cash equivalents, and held-to-maturity short-term investments approximate the carrying amounts reported in the consolidated condensed balance sheets.
The Company’s financial instruments also include accounts receivable and accounts payable. The carrying amounts for these financial instruments reported in the consolidated condensed balance sheets approximate their fair values.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.